| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 37,297 | 38,108 | 31,975 | 18,530 |
| Cost of revenues | 20,189 | 20,350 | 16,237 | 4,529 |
| Gross profit | 17,108 | 17,758 | 15,738 | 14,001 |
| Sales and marketing | 11,848 | 11,868 | 11,999 | 11,877 |
| General and administrative | 11,077 | 12,150 | 13,137 | 7,436 |
| Research and development | 1,504 | 1,798 | 1,616 | 2,416 |
| Total operating expenses | 24,429 | 25,816 | 26,752 | 21,729 |
| Loss from operations | -7,321 | -8,058 | -11,014 | -7,728 |
| Interest expense | 2,206 | 1,969 | 1,922 | 1,725 |
| Other income, net | 126 | 188 | 247 | 539 |
| Net loss | -9,401 | -9,839 | -12,689 | - |
| Gains losses on extinguishment of debt | - | - | - | -4,427 |
| Less net loss attributable to non-controlling interest | -356 | 281 | -14 | - |
| Net loss attributable to neuronetics stockholders' | -9,045 | -10,120 | -12,675 | -13,341 |
| Earnings per share, basic | -0.13 | -0.15 | -0.21 | -0.44 |
| Earnings per share, diluted | -0.13 | -0.15 | -0.21 | -0.44 |
| Weighted average number of shares outstanding, basic | 67,309,000 | 66,180,000 | 61,465,000 | 30,267,000 |
| Weighted average number of shares outstanding, diluted | 67,309,000 | 66,180,000 | 61,465,000 | 30,267,000 |
Neuronetics, Inc. (STIM)
Neuronetics, Inc. (STIM)